Diamond Blackfan Anemia Canada

05/14/2026

Interested in learning more about gene therapy? Please register below

04/19/2026

This is amazing news for the DBA Community. https://www.facebook.com/share/p/18hSfZxw4X/

04/02/2026

DBA Canada is looking for volunteers for the RBC Canadian Open. Please message if you are interested. Benefits include - minimal shift requirement, a free meal, giving back to charity, free admission to the Canadian Open, access to events at the Canadian Open. Volunteers under 16 would need an adult supervise. Great opportunity for students to earn their community hours please share and pm if you are Interested

03/03/2026

Members of the DBAS community may be interested in attending an online Global DBAS Community Teach In taking place tomorrow 1pm EST

This session will bring together researchers, clinicians, scientists, and families from around the world to share information and discuss ongoing areas of research related to DBAS. Topics may include current research efforts, emerging research proposals, and updates related to gene therapy research that is being explored in the field.

Attendees will also have an opportunity to listen to presentations and ask questions of participating medical professionals.

If you would like to attend, please use the registration link below.

Join the Global DBAS Community Teach In online for cool talks and skills sharing with DBAS pros worldwide!

03/01/2026

Rare Disease Day lasts 24 hours.
DBA lasts a lifetime.

When the posts stop and the hashtags fade, families are still scheduling transfusions, monitoring iron levels, coordinating specialists, and waiting for the next research breakthrough.

Progress in Diamond Blackfan Anemia does not happen in a moment. It builds slowly, study by study, registry by registry, collaboration by collaboration. 🧬
It takes:
🔹 Researchers asking better genetic questions
🔹 Physicians refining treatment safety
🔹 Institutions sharing data
🔹 Policymakers paying attention
🔹 A community that refuses to let momentum disappear

Scientific advancement is cumulative. Every donation becomes part of that accumulation. Every contribution helps move timelines forward, even when the movement feels gradual. ⏳

We are not asking for attention.
We are asking for continuity. 💙

If today meant something to you, let it extend beyond today.

Help sustain research, advocacy, and patient support for Diamond Blackfan Anemia.

You can donate through the link in our bio. 🔗

Rare deserves more than one day.

02/28/2026

Rare diseases are often reduced to statistics.

But statistics don’t sit in infusion chairs.
They don’t schedule MRIs.
They don’t manage steroid side effects.
They don’t worry about iron building up in the heart.
Families do.

Diamond Blackfan Anemia is rare in prevalence, but intensive in care. It requires coordinated specialists, long-term monitoring, transfusion management, and constant vigilance to prevent organ damage. This is not episodic treatment. It is a lifelong system.

And systems cost money.

When research funding is scarce, treatment models stagnate.
When collaboration is underfunded, innovation slows.
When infrastructure is weak, families carry more of the burden themselves.

Rare Disease Day is not just about awareness. It is about correcting structural imbalance.

Because small populations still deserve modern medicine.
They still deserve safer therapies.
They still deserve progress.

If you want to help move DBA care forward, not just maintain it, please consider donating through the link in our bio. 🔗

Investment changes timelines.
Investment builds access.
Investment reduces long-term burden.
Rare should never mean overlooked. 💙

02/28/2026

Rare disease is not just a diagnosis. It is a systems issue.

Diamond Blackfan Anemia affects approximately 5–7 per million live births. That number is small. The impact is not.

When a condition is rare, everything changes:
• Fewer specialists with deep expertise
• Care concentrated in major centers
• Families traveling long distances for treatment
• Smaller clinical trials and slower innovation
• Higher per-patient research costs
• Reduced commercial incentive for pharmaceutical development

This is not about importance.
It is about infrastructure.

DBA exists within a healthcare system that was not built for small populations. Traditional research models rely on high patient volume. Investment decisions are influenced by market size. Access to expertise depends on geography.

Rare diseases require a different architecture:
✔️ International collaboration.
✔️ Adaptive trial design.
✔️ Long-term patient registries.
✔️ Sustained nonprofit funding.

That architecture does not build itself.

Awareness matters. But awareness alone does not fund registries, support families, or accelerate research. Action does.

Today, we are asking you to help build the system rare diseases deserve. 🧬

Your donation supports:
• Research innovation
• Clinical collaboration
• Patient advocacy
• Education and long-term infrastructure

Rare deserves research.
Rare deserves expertise.
Rare deserves investment.

If you believe small populations still deserve robust systems of care, please consider donating through the link in our bio or at this link 🔗 https://www.paypal.com/ca/fundraiser/charity/3549420

Structural change requires sustained commitment.
Be part of it. 💙

02/28/2026

Today is Rare Disease Day.
And for families living with Diamond Blackfan Anemia, rare is not abstract. It is daily life.

DBA affects approximately 5–7 per million live births worldwide. That number sounds small. But for the families impacted, it is everything.

Treatment is not simple.

It often includes:
• Chronic blood transfusions
• Steroid therapy
• Ongoing monitoring for iron overload
• Cardiac and liver complication management
• In some cases, stem cell transplantation

These are not short-term interventions. They are lifelong medical realities.

Because DBA is rare, funding is limited.
Because funding is limited, research moves slower.
Because research moves slower, treatment innovation lags behind.

Rare conditions depend on something different:
🌟 Nonprofit research funding.
🌟 Community advocacy.
🌟 Global awareness.
🌟 People who choose to care.

Today, the world shifts its focus to rare diseases 🌍

But awareness without action does not move science forward.

Your support helps fund:
✔ Research advancement
✔ Advocacy initiatives
✔ Patient and family education
✔ Treatment innovation
✔ Long-term care improvements

Rare deserves research.
Rare deserves urgency.
Rare deserves equity ❤️

Donate at the link in bio or directly through the link here: https://www.paypal.com/ca/fundraiser/charity/3549420

Because small populations still deserve big science 🔬

02/27/2026

Tomorrow is Rare Disease Day 💙

Before the world pauses to recognize rare conditions for one day, we want to talk about what happens the other 364.

Most medical research funding follows prevalence. In simple terms: the more common a disease is, the more funding it tends to receive. Rare diseases, by definition, affect fewer people, and that often means:
• Smaller research budgets
• Fewer clinical trials
• Slower treatment development
• Less pharmaceutical investment

Diamond Blackfan Anemia affects approximately 5–7 per million live births. 📊

The patient population is small.
The impact on families is not.

Because DBA is rare, research networks are limited. Large-scale trials are harder to coordinate. Promising therapies can take longer to move forward. Many families still rely on treatment approaches developed decades ago.

This is not due to a lack of urgency.
It is due to a lack of scale.

And that is where community makes the difference 🤝
For rare diseases, progress is often driven by patient advocacy organizations, nonprofit-funded grants, grassroots fundraising, and families who refuse to accept “rare” as a reason to wait.

When large funding systems overlook small populations, communities step in.

Your donation helps:
• Fund targeted DBA research 🔬
• Support affected families 🏠
• Strengthen national advocacy efforts 📣
• Accelerate progress toward better long-term outcomes ⏳

Awareness is powerful.
Action is transformative.

On Rare Disease Day, we invite you to move from awareness to impact.

🔗 Donate at the link in our bio or at this link:
https://www.paypal.com/ca/fundraiser/charity/3549420

Rare diseases deserve research too.
And together, we can help move it forward 💫

02/26/2026

Rare Disease Day is on February 28th, and it’s more than a date on the calendar.

It represents over 300 million people worldwide living with conditions that most of the world has never heard of🌍

A disease is considered rare when it affects a small percentage of the population. But rare does not mean insignificant. There are more than 7,000 identified rare diseases, and together they impact millions of families across the globe.

Diamond Blackfan Anemia is one of them🩸

DBA affects approximately 5–7 per million live births. Children born with DBA cannot produce enough red blood cells to sustain their bodies. Many require lifelong transfusions, steroid therapy, careful iron monitoring, and in some cases, stem cell transplantation.

Because DBA is rare:
• Research funding is limited
• Public awareness is low
• Diagnosis can be delayed
• Families often navigate complex medical decisions with little visibility or understanding

Rare Disease Day exists to change that.

Awareness influences policy.
Policy influences funding.
Funding drives research.
Research improves treatment.
Treatment changes lives.

Behind every statistic is a child in a hospital room, a parent advocating for answers, and a family adjusting to a diagnosis they may have never heard of before❤️
Rare should never mean invisible.

If you would like to support research, advocacy, and patient support for Diamond Blackfan Anemia, you can share this post and donate here or at the link in our bio:
🔗 https://www.paypal.com/ca/fundraiser/charity/3549420

Your contribution helps fund:
• Research initiatives
• Patient support programs
• Educational resources
• Advocacy efforts

Together, we can ensure that rare diseases, and the families affected by them, are seen, supported, and prioritized.